mTOR aggravated CD4++ T cell pyroptosis by regulating the PPARγ-Nrf2 γ-Nrf2 pathway in sepsis

被引:1
|
作者
Zhao, Guoyu [1 ]
Xie, Yawen [1 ]
Lei, Xianli [1 ]
Guo, Ran [1 ]
Cui, Na [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, State Key Lab Complex Severe & Rare Dis, Dept Crit Care Med, Beijing 100730, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
mTOR; Pyroptosis; PPAR gamma; Nrf2; Sepsis; CD4+T cell; INDUCED IMMUNOSUPPRESSION; ACTIVATION;
D O I
10.1016/j.intimp.2024.112822
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is a systemic inflammatory response syndrome caused by a dysregulated host response to infection. CD4+T + T cell reduction is crucial to sepsis-induced immunosuppression. Pyroptosis, a programmed necrosis, is concerned with lymphocytopenia. Peroxisome proliferator-activated receptor gamma (PPAR gamma) regulated by upstream mTOR, exerts anti-pyroptosis effects. To investigate the potential effects of mTOR-PPAR gamma on sepsis-induced CD4+T + T cell depletion and the underlying mechanisms, we observed mTOR activation and pyroptosis with PPAR gamma-Nrf suppression through cecal ligation and puncture (CLP) sepsis mouse model. Further mechanism research used genetically modified mice with T cell-specific knockout mTOR or Tuberous Sclerosis Complex1 (TSC1). It revealed that mTOR mediated CD4 + T cell pyroptosis in septic mice by negatively regulating the PPAR gamma-Nrf2 signaling pathway. Taken together, mTOR-PPAR gamma-Nrf2 signaling mediated the CD4+ + T cell pyroptosis in sepsis, contributing to CD4+T + T cell depletion and immunosuppression.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Nrf2 pathway in patients with Parkinson's disease
    Schirinzi, T.
    Petrillo, S.
    Di Lazzaro, G.
    Mercuri, N.
    Bertini, E.
    Piemonte, F.
    Pisani, A.
    MOVEMENT DISORDERS, 2019, 34
  • [42] Repression of the Antioxidant NRF2 Pathway in Premature Aging
    Kubben, Nard
    Zhang, Weiqi
    Wang, Lixia
    Voss, Ty C.
    Yang, Jiping
    Qu, Jing
    Liu, Guang-Hui
    Misteli, Tom
    CELL, 2016, 165 (06) : 1361 - 1374
  • [43] Nrf2: new insight in cell apoptosis
    M Bonay
    T B Deramaudt
    Cell Death & Disease, 2015, 6 : e1897 - e1897
  • [44] The Study of Nrf2 Signaling Pathway in Ovarian Cancer
    Wu, Xiaotong
    Han, Li Ying
    Zhang, Xiao Xiao
    Wang, Ling
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2018, 28 (04): : 329 - 336
  • [45] Effects of atmospheric pollutants on the Nrf2 survival pathway
    Valentina Rubio
    Mahara Valverde
    Emilio Rojas
    Environmental Science and Pollution Research, 2010, 17 : 369 - 382
  • [46] VALIDATION OF NRF2 PATHWAY DYSREGULATION IN UROTHELIAL CARCINOMA
    Birch, Brian
    Lwaleed, Bashir
    Cooper, Alan
    Harper, Phil
    Giatsidou, Iliana
    JOURNAL OF UROLOGY, 2017, 197 (04): : E640 - E641
  • [47] Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
    Liddell, Jeffrey R.
    Lehtonen, Sarka
    Duncan, Clare
    Keksa-Goldsteine, Velta
    Levonen, Anna-Liisa
    Goldsteins, Gundars
    Malm, Tarja
    White, Anthony R.
    Koistinaho, Jari
    Kanninen, Katja M.
    JOURNAL OF NEUROINFLAMMATION, 2016, 13
  • [48] Targeting the Nrf2 pathway against cardiovascular disease
    Li, Jinqing
    Ichikawa, Tomonaga
    Janicki, Joseph S.
    Cui, Taixing
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 785 - 794
  • [49] Selenium mitigates ferroptosis-mediated dopaminergic cell death by regulating the Nrf2/GPX4 pathway
    Jung, Yu Jin
    Choi, Hyunsu
    Oh, Eungseok
    NEUROSCIENCE LETTERS, 2023, 810
  • [50] Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
    Telkoparan-Akillilar, Pelin
    Panieri, Emiliano
    Cevik, Dilek
    Suzen, Sibel
    Saso, Luciano
    MOLECULES, 2021, 26 (05):